Srinivas Ayyadevara Selected Research

2,3-trimethylene-4-quinazolone

1/2021

Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Srinivas Ayyadevara Research Topics

Disease

10	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 02/2015
9	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2017
4	Neuroblastoma 01/2021 - 12/2017
3	Multiple Myeloma 02/2016 - 01/2014
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2018
2	Neoplasms (Cancer) 12/2017 - 01/2015
1	Neuroinflammatory Diseases 01/2019
1	Amyloid Plaque 01/2019
1	Nervous System Diseases (Neurological Disorders) 12/2017
1	Parkinson Disease (Parkinson's Disease) 12/2017
1	Huntington Disease (Huntington's Disease) 12/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Sarcopenia 12/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2016
1	Hypertension (High Blood Pressure) 05/2016
1	Paralysis (Palsy) 02/2015
1	Acute Kidney Injury (Acute Renal Failure) 08/2012
1	Hypercholesterolemia 08/2011
1	Atherosclerosis 08/2011
1	Hypoxia (Hypoxemia) 12/2010

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2015
4	Amyloid (Amyloid Fibrils)IBA 01/2021 - 02/2015
4	Protein AggregatesIBA 10/2018 - 05/2016
3	Pharmaceutical PreparationsIBA 10/2019 - 12/2016
2	Peptides (Polypeptides)IBA 01/2021 - 01/2021
2	Apolipoprotein E3IBA 01/2021 - 01/2018
2	Apolipoprotein E4IBA 01/2021 - 01/2018
2	Apolipoproteins E (ApoE)IBA 01/2018 - 05/2016
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2017 - 12/2010
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	AcetylcholinesteraseIBA 01/2021
1	2,3-trimethylene-4-quinazoloneIBA 01/2021
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2021
1	ButyrylcholinesteraseIBA 01/2021
1	MetalsIBA 08/2020
1	Indicators and Reagents (Reagents)IBA 10/2019
1	CytokinesIBA 01/2019
1	Insulin-Like PeptidesIBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	Protein PrecursorsIBA 01/2019
1	SalicylatesIBA 12/2017
1	Cyclooxygenase InhibitorsIBA 12/2017
1	SynucleinsIBA 12/2017
1	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Clodronic Acid (Clodronate)IBA 01/2017
1	Angiotensin IIIBA 05/2016
1	ClusterinIBA 05/2016
1	Detergents (Detergent)IBA 05/2016
1	Complement C3 (C3 Complement)IBA 05/2016
1	dinaciclibIBA 02/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2016
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2016
1	veliparibIBA 02/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2015
1	Peptide Nucleic AcidsIBA 01/2015
1	Melphalan (Alkeran)FDA LinkGeneric 01/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014
1	Triglycerides (Triacylglycerol)IBA 08/2012
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 08/2012
1	Cisplatin (Platino)FDA LinkGeneric 08/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2012
1	oxidized low density lipoproteinIBA 08/2011
1	matrigelIBA 12/2010

Therapy/Procedure

2	Therapeutics 01/2021 - 02/2016
1	Photothermal Therapy 10/2021
1	Precision Medicine 10/2021